Cancer Research Breakthroughs Archives - Page 2 of 6 - NFCR

Cancer Research Breakthroughs

Breakthrough: Dr. César Milstein And The MAbs

They are called “mAbs,” short for monoclonal antibodies, and they are a big deal in oncology. One of the immune systems most elegant soldiers, mAbs are formed by B cells, a type of white blood cell produced in the spleen, in response to specific foreign invaders (real and perceived) known…...

Read more

At Its Root

Chaos can be surprisingly orderly. While cancer is characterized by uncontrolled cell growth, that growth is, nevertheless, the result of a very particular cascade of events, from carcinogen exposure to genetic mutations. Interfere with that cascade, and cancer can be ground to a halt, or even killed off. The efforts…...

Read more

Ancient Wisdom, Modern Cure

“Chinese traditional medicine” (TCM) is a cultural catch-all term for a series of practices including herbal medicine, diet, acupuncture, massage and exercise (like tai chi) whose combined history stretches back over four thousand years. Western science acknowledges the benefits of some forms of TCM — acupuncture and Chinese massage techniques,…...

Read more

An Analytical Tool Like Few Others

When he passed away in April 2004, Dr. Csaba Horváth had more than a few laurels upon which he could eternally rest. Though most famously, Horváth was the first scientist to design, construct and show molecular separations using high-performance liquid chromatography (HPLC). The analytical technology has since served as foundation…...

Read more

Crizotinib Plus Radiation May Reduce NF2-Related Hearing Loss

A study co-authored by National Foundation for Cancer Research Fellow Dr. Rakesh Jain hints that adding the cancer drug crizotinib to the radiation therapy for tumors associated with neurofibromatosis 2 (NF2) may lessen the hearing loss that often precipitates from radiotherapy. Although not a cancer, NF2 is characterized by benign…...

Read more